Andere talen Molecular Partners AG

Aandelen

MOLN

CH0256379097

Beurs gesloten - Swiss Exchange Andere beurzen 17:30:10 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,315 ^CHF	+0,76%		-2,93%	-3,63%

29/04	Molecular Partners AG kondigt de publicatie aan in Cancer Immunology Research van preklinische gegevens die het voorgestelde werkingsmechanisme van MP0533 ondersteunen	CI
15/03	Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Morning Briefing - Markt Schweiz	30/04
Molecular Partners mit positivem Expertenbericht zum Leukämie-Kandidat MP0533	29/04
Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action	29/04
Molecular Partners AG Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action	29/04
Molecular Partners : Annual General Meeting Minutes	26/04
Life Science Cares Launches in Switzerland	19/04
Molecular Partners : statement regarding Passive Foreign Investment Company status	18/04
Principales informations avant-Bourse	18/04
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting	17/04
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting	17/04
Morning Briefing - Markt Schweiz	17/04
Morning Briefing - Markt Schweiz	16/04
Morning Briefing - Markt Schweiz	15/04
Morning Briefing - Markt Schweiz	08/04
Principales informations avant-Bourse	08/04
Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement	01/04
Molecular Partners Publishes Invitation to Annual General Meeting 2024	26/03
Molecular Partners Publishes Invitation to Annual General Meeting 2024	26/03
Molecular Partners : Einladung zur ordentlichen Generalversammlung 2024	21/03
Morning Briefing - Markt Schweiz	15/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Molecular Partners AG

Aandelen

MOLN

CH0256379097

Andere talen

Filters